Perspective Therapeutics Inc (CATX)

개요 뉴스 가격 이력 토론 예측 주식 분할

Relative Volume:

Perspective Therapeutics Inc Stock (CATX) Company Profile

Perspective Therapeutics Inc

Healthcare (1083)

Medical Devices (140)

509-375-1202

350 Hills Street, Suite 106, Richland

최신 SEC 제출 서류

CATX's Discussions on Twitter

Compare CATX vs ABT, SYK, MDT, BSX, EW

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
CATX Perspective Therapeutics Inc	3.335	397.25M	618.00K	-111.65M	-107.53M	-1.396
ABT Abbott Laboratories	114.75	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	330.92	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	92.36	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	49.62	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.54	53.19B	6.30B	1.07B	1.09B	1.8406

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-02-19	개시	Piper Sandler	Overweight
2025-11-24	재개	Truist	Buy
2025-10-10	개시	BTIG Research	Buy
2025-03-13	개시	H.C. Wainwright	Buy
2025-03-07	개시	Scotiabank	Sector Outperform
2024-11-25	다운그레이드	BofA Securities	Buy → Neutral
2024-10-24	개시	UBS	Buy
2024-10-01	개시	Wedbush	Outperform
2024-09-25	개시	Truist	Buy
2024-07-25	개시	BofA Securities	Buy
2024-05-09	개시	Cantor Fitzgerald	Overweight

Perspective Therapeutics Inc 주식(CATX)의 최신 뉴스

Perspective Therapeutics Inc (CATX) 재무 분석

Perspective Therapeutics Inc (CATX)

Perspective Therapeutics Inc Stock (CATX) Company Profile

Compare CATX vs ABT, SYK, MDT, BSX, EW

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

Perspective Therapeutics Inc 주식(CATX)의 최신 뉴스

BMO Capital Markets Upgrades Perspective Therapeutics (NYSEAMERICAN:CATX) to "Strong-Buy" - MarketBeat

Perspective (CATX) Range: Posts a 8.41% Gain to $3.48 for the Current Session; Chart View - Vinanet

PERSPECTIVE THERAPEUTICS INC : BMO INITIATES COVERAGE WITH OUTPERFORM RATING; PRICE TARGET $11 - Bitget

Perspective Therapeutics Market Sentiment - Benzinga France

CATX Initiated by BMO Capital -- Rating Set to Outperform - GuruFocus

Perspective Therapeutics Price Target Announced at $11.00/Share by BMO Capital - Moomoo

BMO initiates Perspective Therapeutics stock at Outperform, $11 target By Investing.com - Investing.com India

BMO initiates Perspective Therapeutics stock at Outperform, $11 target - Investing.com

BMO Capital Initiates Perspective Therapeutics at Outperform - marketscreener.com

BMO Capital Initiates Coverage on CATX with Outperform Rating, H - GuruFocus

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

CATX Q1 2026 Earnings: Loss Beats Estimates by 17.25%, Shares Rise 3.23%Revenue Growth Outlook - Vinanet

CATX Maintained by B of A Securities -- Price Target Lowered to $5.00 - GuruFocus

Bank of America Lowers Perspective Therapeutics (NYSEAMERICAN:CATX) Price Target to $5.00 - MarketBeat

BofA Securities Maintains Perspective Therapeutics(CATX.US) With Hold Rating, Cuts Target Price to $5 - Moomoo

Q3 EPS Forecast for Perspective Therapeutics Lifted by Analyst - MarketBeat

BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 - marketscreener.com

Dimensional Fund Advisors LP Acquires 358,540 Shares of Perspective Therapeutics, Inc. $CATX - MarketBeat

Perspective Therapeutics (CATX) Stock Price, News & Analysis - marketbeat.com

Perspective Therapeutics (CATX): Millennium group reports over 5% beneficial stake - Stock Titan

Analysts Set Expectations for Perspective Therapeutics Q1 Earnings - MarketBeat

RBC Capital Sticks to Their Buy Rating for Perspective Therapeutics (CATX) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Atossa Therapeutics (ATOS), Corvus Pharmaceuticals (CRVS) and Perspective Therapeutics (CATX) - The Globe and Mail

Perspective Therapeutics, Inc. (CATX) Latest Stock News & Headlines - Yahoo Finance

Perspective Therapeutics (CATX) Gets a Buy from Oppenheimer - The Globe and Mail

Piper Sandler cuts Perspective Therapeutics price target on timing By Investing.com - Investing.com Australia

Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says - marketscreener.com

Piper Sandler cuts Perspective Therapeutics price target on timing - Investing.com

CATX Maintained by Piper Sandler -- Price Target Lowered to $14. - GuruFocus

Perspective Therapeutics (NYSEAMERICAN:CATX) Price Target Lowered to $14.00 at Piper Sandler - MarketBeat

Perspective Therapeutics Price Target Cut to $14.00/Share From $16.00 by Piper Sandler - Moomoo

Perspective Therapeutics (CATX) Climbs 4.7% to $3.14 as Buyers Defend Key SupportValue ETF - Vinanet

Perspective Therapeutics earnings beat by $0.04, revenue fell short of estimates - Investing.com Canada

Perspective Therapeutics Reports Q2 Results and Pipeline Progress - TipRanks

Perspective Therapeutics Q2 FY26 net loss widens to $26.8 million - Bitget

Perspective Therapeutics (NYSEAMERICAN:CATX) Announces Quarterly Earnings Results - MarketBeat

Form 8K Perspective Therapeutics Inc For: 10 August By Investing.com - Investing.com Australia

Perspective Therapeutics Q2 EPS beats estimates as sales miss consensus - scanx.trade

Perspective Therapeutics: Q2 Earnings Snapshot - AOL.com

Perspective Therapeutics Reports $26.8 Million Q2 Net Loss - Quiver Quantitative

Perspective Therapeutics (CATX) expands cash to $236.9M while losses widen - Stock Titan

Perspective Therapeutics Q2 net loss widens on higher R&D costs - TradingView

Perspective Therapeutics (NYSE: CATX) grows cash to $237M while advancing Phase 3-ready pipeline - Stock Titan

Perspective Therapeutics Advances VMT-α-NET Toward Phase 3 as Pipeline and Manufacturing Expansion Progresses - Quiver Quantitative

Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2026 Results - The Manila Times

Perspective Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

MSN Money - MSN

Perspective Therapeutics Inc (CATX) Stock News Today - TradingKey

Perspective Therapeutics Inc (CATX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

State Street Corporation (NYSE: CATX) reports 6.05M-share, 5.3% stake in Perspective - Stock Titan

Perspective Therapeutics (CATX) to Announce Earnings on Wednesday - MarketBeat

Perspective Therapeutics Inc (CATX) 재무 분석

매출

순이익

현금흐름

주당 순 이익

CATX과 유사한 종목